Enhancing Comprehensive Assessments in Chronic Heart Failure Caused by Ischemic Heart Disease: The Diagnostic Utility of Holter ECG Parameters

被引:1
|
作者
Duca, Stefania-Teodora [1 ,2 ]
Tudorancea, Ionut [2 ,3 ]
Haba, Mihai Stefan Cristian [1 ,2 ]
Costache, Alexandru-Dan [1 ,4 ]
Serban, Ionela-Lacramioara [3 ]
Paval, D. Robert [5 ]
Loghin, Catalin [6 ]
Costache-Enache, Irina-Iuliana [1 ,2 ]
机构
[1] Univ Med & Pharm Grigore T Popa, Fac Med, Dept Internal Med 1, Iasi 700115, Romania
[2] St Spiridon Emergency Cty Hosp, Dept Cardiol, Iasi 700111, Romania
[3] Univ Med & Pharm Grigore T Popa, Dept Morpho Funct Sci Physiol 2, Iasi 700115, Romania
[4] Clin Rehabil Hosp, Dept Cardiovasc Rehabil, Iasi 700661, Romania
[5] Univ Stirling, Fac Hlth Sci & Sport, Stirling FK9 4LA, Scotland
[6] Univ Texas, Dept Internal Med, Cardiol Div, Hlth Sci Ctr, Houston, TX 77030 USA
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 08期
关键词
ischemic heart disease; chronic heart failure; 24 h Holter ECG; SUDDEN CARDIAC DEATH; T-WAVE ALTERNANS; CORONARY-ARTERY-DISEASE; RATE-VARIABILITY; 24-HOUR HOLTER; DECELERATION CAPACITY; RATE TURBULENCE; RISK; ELECTROCARDIOGRAM; MORTALITY;
D O I
10.3390/medicina60081315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Chronic heart failure (CHF) caused by ischemic heart disease (IHD) is the leading cause of death worldwide and presents significant health challenges. Effective management of IHD requires prevention, early detection, and treatment to improve patient outcomes. This study aims to expand the diagnostic utility of various 24 h Holter ECG parameters, such as T-wave alternans (TWA), late ventricular potentials (LVPs), and heart rate variability (HRV) in patients with CHF caused by IHD. Additionally, we seek to explore the association between these parameters and other comorbid conditions affecting the prognosis of CHF patients. Materials and Methods: We conducted a prospective case-control study with 150 patients divided into two subgroups: 100 patients with CHF caused by IHD, and 50 patients in the control group. Data included medical history, physical examination, laboratory tests, echocardiography, and 24 h Holter monitoring. Results: Our comparative analysis demonstrated that both TWA and LVPs were significantly higher in patients with CHF compared to the control group (p < 0.01), indicating increased myocardial electrical vulnerability in CHF patients. Both time and frequency-domain HRV parameters were significantly lower in the CHF group. However, the ratio of NN50 to the total count of NN intervals (PNN50) showed a borderline significance (p = 0.06). While the low-frequency (LF) domain was significantly lower in CHF patients, the high-frequency (HF) domain did not differ significantly between groups. Acceleration and deceleration capacities were also significantly altered in CHF patients. Categorizing CHF patients by left ventricular ejection fraction (LVEF) revealed that the mean of the 5-min normal-to-normal intervals over the complete recording (SDNN Index) was significantly higher in patients with LVEF >= 50% compared to those with CHF with reduced EF and CHF with mildly reduced EF (p < 0.001), whereas the other HRV parameters showed no significant differences among the groups. Conclusions: Holter ECG parameters can become a reliable tool in the assessment of patients with CHF. The integration of multiple Holter ECG parameters, such as TWA, LVPs, and HRV, can significantly enhance the diagnostic assessment of CHF caused by IHD. This comprehensive approach allows for a more nuanced understanding of the patient's condition and potential outcomes.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease - ECG-findings in a population-based cohort study
    Nilsson, Ulf
    Johansson, Bengt
    Eriksson, Berne
    Blomberg, Anders
    Lundback, Bo
    Lindberg, Anne
    BMC PULMONARY MEDICINE, 2015, 15
  • [32] Clinical and Laboratory Parameters of Patients with Ischemic Heart Disease Complicated by Heart Failure of III-IV Functional Class with The Inclusion of Plasmapheresis in The Treatment Program
    Evgenievich, Malchevsky Yury
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (03): : 419 - 424
  • [33] Effects of beta-adrenoblockers on myocardial remodeling, immuno-inflammatory reactions and endothelial dysfunction in patients with ischemic heart disease and chronic heart failure
    Zakirova, A. N.
    Zakirova, N. E.
    Karamova, I. M.
    Khafizov, N. Kh.
    Rasskazova, O. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2007, 3 (04) : 19 - 24
  • [34] Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review
    Jiayuan Hu
    Ruijin Qiu
    Chengyu Li
    Min Li
    Qianqian Dai
    Shiqi Chen
    Chen Zhao
    Hongcai Shang
    BMC Complementary Medicine and Therapies, 21
  • [35] Global trends and disparities in the burden of heart failure caused by chronic kidney disease: an analysis of the global burden of disease study 2021
    Ye, Lingxia
    Huang, Xin
    Xu, Yufeng
    FRONTIERS IN MEDICINE, 2025, 12
  • [36] Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review
    Hu, Jiayuan
    Qiu, Ruijin
    Li, Chengyu
    Li, Min
    Dai, Qianqian
    Chen, Shiqi
    Zhao, Chen
    Shang, Hongcai
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [37] B-type natriuretic peptide predicts an ischemic etiology of acute heart failure in patients with stage 4-5 chronic kidney disease
    Kim, Sung Eun
    Park, Sunghoon
    Kim, Jwa-Kyung
    Kim, Sung Gyun
    Kim, Hyung Jik
    Song, Young Rim
    CLINICAL BIOCHEMISTRY, 2014, 47 (06) : 344 - 348
  • [38] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Nick Kontodimopoulos
    Michalis Argiriou
    Nikolaos Theakos
    Dimitris Niakas
    The European Journal of Health Economics, 2011, 12 : 383 - 391
  • [39] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Kontodimopoulos, Nick
    Argiriou, Michalis
    Theakos, Nikolaos
    Niakas, Dimitris
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (04) : 383 - 391
  • [40] Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Metalloproteinase 1 (TIMP-1) Genes as a Diagnostic and Prognostic Marker of Heart Failure Due to Ischemic Heart Disease
    Korzen, Dariusz
    Sierka, Oskar
    Dabek, Jozefa
    BIOMEDICINES, 2023, 11 (10)